Blepharitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TARS | A | Tarsus Pharmaceuticals, Inc. | -2.30 | |
KALA | B | Kala Pharmaceuticals, Inc. | -3.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | B | SPDR S&P Pharmaceuticals ETF | 2.69 | |
BBP | A | BioShares Biotechnology Products Fund | 1.74 | |
PILL | B | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 1.69 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 1.12 | |
IHE | D | iShares U.S. Pharmaceutical ETF | 0.62 |
Compare ETFs
- Blepharitis
Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. Although blepharitis is not sight-threatening, it can lead to permanent alterations of the eyelid margin. The overall etiology is a result of bacteria and inflammation from congested meibomian oil glands at the base of each eyelash. Other conditions may give rise to blepharitis, whether they be infectious or noninfectious, including, but not limited to, bacterial infections or allergies.
Different variations of blepharitis can be classified as seborrheic, staphylococcal, mixed, posterior or meibomitis, or parasitic. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis, which can affect all ages and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the average age of patients was 50 years old.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles